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Introduction
Three-dimensional (3D) X-ray breast imaging techniques have been developed having in mind the limits of projection mammography related to the superimposition of tissues, which may affect the detectability of mass lesions. Indeed, tomographic techniques like X-ray computed tomography (CT) are known to reproduce with high contrast the body or organ 3D anatomy. Digital breast tomosynthesis (DBT)-which produces pseudo-tomographic 3D images of the compressed breast with anisotropic resolution [1] [2] [3] [4] -is routinely adopted in the clinic for second level examinations; clinical reports for its application in screening studies have been presented recently [5] . In the last few years, following the techniques and scanning strategy initially proposed by Boone et al. [6] and Chen and Ning [7] , cone-beam CT dedicated to the breast (BCT) [6] [7] [8] [9] [10] [11] [12] [13] received regulatory approval in USA and marketing licence in the European Union (for a recent review, see [14] ). BCT produces sectional images of the uncompressed breast with isotropic resolution and excellent contrast sensitivity [8, 9] . As a fully 3D technique, it eliminates tissue superimposition, and it may reduce the patient discomfort due to the absence of breast compression [8] , as opposed to mammography and the limited-arc tomographic technique of DBT. As regards the imaging radiation dose, the dose metric, both in 2D and in 3D X-ray breast imaging, is the mean glandular dose (MGD) (mGy), i.e. the ratio of the energy absorbed in the whole volume of breast glandular tissue to its mass. The MGD is adopted for cancer risk estimates in mammography [15] as well as in DBT [1, 16] , and it is considered for image quality comparisons in such breast imaging procedures [17] . In two-view digital mammography, an average MGD value of 3.7 mGy has been reported [15] . The concept of MGD was introduced as a figure of merit for comparing the radiation dose among different breast imaging techniques [18] and the energy absorbed in glandular tissue, E g , was considered the meaningful quantity for radiation risk estimates. In Hammerstein et al.'s words, "Detailed information will have to be obtained on the amount and distribution of gland tissue in many individual cases before E g can be applied properly to the problem of individual risk" [18] . Such detailed information is still lacking in the literature, and collective risk estimates in breast imaging are based on the MGD metric, on the assumption of a homogeneous distribution of the gland in the breast [19] . This last is well recognized as an unrealistic condition, given the wide variability of the total gland mass and its location in the breast volume, though the gland is usually considered as concentrated towards the centre of the breast [20] . Models of radio-induced cancer risk in X-ray breast imaging based on patient-specific anatomical data will need the assessment of the 3D glandular dose distribution.
Since measurements of the absorbed energy or of the glandular mass are not possible in vivo, in each exam the MGD is estimated for a breast model, from Monte Carlo (MC) simulations of the imaging setup. In these estimates, the specific anatomy of the patient is not modelled, apart from measurement of its compressed breast thickness and estimation of its average glandular fraction by weight (i.e. the ratio of the total glandular mass to the mass of adipose and fibroglandular tissue in the breast).
The protocols for MGD estimates in 2D mammography are well defined and routinely adopted [21] [22] [23] [24] . Recently, a protocol which includes guidelines for dose estimation in DBT has been produced [25] . In addition, a joint AAPM/EFOMP task group 1 is dedicated to defining a protocol for MGD estimates in screening and diagnostic mammography and DBT. In all protocols, the simulations produce dimensionless coefficients of MGD per unit air kerma (mGy/mGy), so-called coefficients of normalized glandular dose (DgN) or the triad of coefficients (c, g, s) as proposed in Refs. [21] [22] [23] [24] . Cone-beam BCT (also in conjunction with mammography) is being investigated clinically for breast cancer diagnosis [8, 9] . The MGD in each BCT scan can be derived by adopting suitable DgN CT coefficients, as conversion factors from the air kerma at the scanner isocentre to the MGD [12, [26] [27] [28] [29] . For a given breast, DgN CT coefficients depend on the breast dimensions (diameter at the chest wall and length) and breast glandularity as well as on the X-ray beam spectrum. Boone et al. [26] modelled the breast as a cylinder of homogenous mixture of glandular and adipose tissue enveloped in a layer "equivalent" to 4-mm thick skin. They provided (via MC simulations) polyenergetic DgN CT coefficients for their in-house developed BCT scanner. Thacker and Glick [27] used a model similar to that proposed by Boone et al. [26] (cylindrical shape and 4-mm thick skin) and studied the impact of different assumptions. In particular, they investigated the impact of modelling the breast as a semi-ellipsoid and introduced the breast length as a parameter for the calculation of the monoenergetic DgN CT coefficients. Moreover, they investigated the influence of using a skin of 2-mm thickness instead of 4 mm. Indeed, the skin thickness ranges between 0.5 mm and 2 mm [30] rather than the 4-5 mm adopted in dosimetric protocols for MGD estimates [19] . Skin thickness measurements from 3D images of the breast indicated an average value of 1.45 mm [31, 32] . For this reason, Sechopoulos et al. [28] , in the determination of DgN CT coefficients for a Koning Corp. cone-beam BCT apparatus (http:// koninghealth.com/), modelled the breast with a semi-ellipsoidal shape enveloped in a 1.45 mm layer mimicking the skin. The same shape for the pendant breast was adopted in Ref. [33] , where the authors showed -via MC simulations and laboratory measurements on PMMA phantoms − the highest uniformity of the dose spread in the breast volume in a BCT scan, with respect to two-view mammography.
In addition to 2D and DBT imaging [34] , BCT with a monoenergetic, parallel beam from a synchrotron radiation source and the patient in prone position is under investigation at the Elettra facility (Trieste, Italy) [35] [36] [37] [38] . In that experimental project, the patient is placed on a rotating and vertically translating bed with her breast freely hanging from a hole. The use of a synchrotron radiation beam implies that only a thin section (few mm in the vertical direction) of the breast can be imaged during a rotation; this specific irradiation geometry led to the definition of two new dose metrics -MGDt and MGDv -which take into account the dose to the total glandular mass in the organ and to the sole irradiated volume, respectively [39] . This strategy for MGD definition in partial breast irradiation was adopted also when investigating the MGD for spot mammography [40] .
Recent papers [41, 42] showed that, in mammography, the assumption of homogeneous glandular and adipose mixture within the breast may lead to an average MGD overestimation of 30%. This overestimation decreases to 10% in the case of BCT at 49 kVp (i.e. the tube voltage of the Koning Corp. apparatus) and it is even lower for higher X-ray energies [41] . Yi et al. [29] showed similar results by adopting 3D images of mastectomy breast specimens. Hence, they compared, via MC simulations, dose estimates with structured breast digital models and simple homogeneous breast models, showing slight differences. In addition, Hernandez et al. [43] produced DgN CT coefficients by adopting digital breast models, which reflect the real breast silhouette, but not the real glandular distribution. They showed that these models do not lead to large MGD differences when compared to results for cylindrical breast models.
This work aimed at defining a simple homogenous breast model for DgN CT evaluation and providing a complete monoenergetic (DgN CT (E)) and polyenergetic (pDgN CT ) coefficients dataset for MGD estimates in cone-beam BCT. Here the pendant breast, modelled as a homogeneous mixture of adipose and glandular tissues, is a cylinder with a 1.45-mm thick skin layer. DgN CT (E) were computed for X-ray photon energies up to 82.5 keV and they were fitted with polynomial curves. Fitting coefficients were released for its usage in applications with generic produced spectra or for applications which employs monoenergetic X-ray beams. pDgN CT were computed for spectra adopted in the clinical practice. For a fixed anode/filter combination, several coefficients were computed in order to cover a broad range of X-ray beam HVL. To our best knowledge, this work presents values for cone-beam breast CT dosimetry coefficients based on up-to-date breast models in the widest set of parameters (geometry, composition and photon energy) presently available.
Finally, we adopted a series of digital patient-specific breast phantoms derived from clinical cone-beam BCT images − which have the silhouette and the heterogeneous glandular tissue distribution of real breasts − for devising patient specific phantoms. These phantoms were input in the MC simulations and the calculated MGD and glandular dose distributions were compared to those obtained for homogenous cylindrical breast model in order to validate the proposed simple homogeneous model.
Materials and methods

Normalized glandular dose in breast CT
In cone-beam BCT, the MGD is estimated from the air kerma at the scanner isocenter (K) [26] [27] [28] as follows:
In the MC simulations for DgN CT computation, the geometries, the technique factors and the breast models have to reflect those of a real BCT exam.
Homogeneous breast model and irradiation geometry
The breast was modelled as a cylinder composed of a homogeneous mixture of glandular and adipose tissue surrounded by a thin layer simulating the skin. The composition of the skin and of the homogeneous breast tissue are those provided by Hammerstein et al. [18] . The uniform skin thickness was 1.45 mm [31] ; moreover, the effect of modifying the skin thickness on the DgN CT was investigated in this work. The DgN CT coefficients have been evaluated for breast diameters in the range 8-18 cm (with 2 cm step), for glandular fractions by mass of 0.1%, 25%, 50% and 100% and for breast lengths equal to 1, 1.5 and 2 times the cylindrical breast radius. The chest wall was modelled as a water box of size 300 × 300 × 150 cm 2 .
The radiation source was placed at 650 mm from the isocenter and the isotropic X-ray cone beam was electronically collimated in order to irradiate a 400 × 300 mm 2 surface, representing the flat panel detector, at 923 mm from the source (Fig. 1 ). The distance between the chestwall and the X-ray central beam (i.e. the ray from the X-ray tube focal spot which impacts perpendicular to the detector) was 0 mm.
Monte Carlo simulations 2.3.1. Monoenergetic DgN CT
In order to calculate the DgN CT (E) coefficients, we adopted a previously validated MC code [39, [44] [45] [46] . It relies on the GEANT4 toolkit version 10.00 and employs the low energy physics list Option4. The photoelectric, incoherent and coherent scatter photon interactions have been simulated. The electrons were tracked and also the bremsstrahlung processes were simulated, although they present a small influence on the MGD calculation in the investigated energy range 8-80 keV for mammographic geometries [44] . The average dose to glandular tissue has been evaluated as follows:
where E i dep is the energy absorbed in the homogeneous tissue at the i-th interaction, f g is the breast glandular fraction by mass evaluated without considering the skin and W b is the breast mass (skin excluded). The factor G i (E) is computed as follows:
μ en /ρ is the mass energy absorption coefficient of glandular (subscript g) and adipose (subscript a) tissues, evaluated by considering the functional interpolation given in Ref. [47] . It is evaluated at the actual energy E of the last interacting photon. The air kerma, K, was evaluated at the scanner isocenter by scoring the photons in a 18 × 30 mm 2 region placed with the upper edge (18 mm long) in contact with the chest-wall. This size reflects the sensitive volume cross section of a 6 cm 3 ion chamber. It was computed from the scored photons as in [48] :
where E i is the energy of the i-th photon which passes through the scoring surface of area S, μ en /ρ air is the mass energy absorption coefficient of the (dry) air obtained from the NIST database and θ i is the angle between the photon direction and the normal to S. Both the breast and chest-wall were removed from the simulation geometry during the calculation of K. Finally, the monoenergetic DgN CT (E) was calculated:
The simulations were run with a monoenergetic X-ray beam with photon energy E covering the range between 4.25 keV and 82.25 keV, with a sampling step of 0.5 keV. In order to reduce the amount of output data in the final datasheet, the DgN CT (E) curves, as a function of the primary beam energy, were fit with 8th-order polynomial functions. The final fitting curves dataset is limited in the range 8-80 keV, so excluding unexpected values due to the boundary conditions. Both K and MGD were computed with a statistical uncertainty lower than 0.1%, this last evaluated as suggested by Sempau et al. [49] .
Polyenergetic DgN CT
The pDgN CT coefficients were computed from the monoenergetic DgN CT as suggested by Boone et al. [50] :
where ϕ(E) is the normalized spectrum at K scoring surface (photons/ mm 2 ), ϑ(E) is the photon fluence to air kerma conversion factor (mGy•mm 2 /photons), and ΔE is the DgN(E) evaluation sampling pitch. The pDgN CT were computed for X-ray spectra adopted for the Koning Corp. BCT scanner [28] , produced with a W anode and an added Al filtration. Although in Ref. [28] the X-ray beam HVL for this scanner was assessed to be 1.39 mm Al, it might slightly vary between the different Koning Corp. BCT units. In order to cover a broader range of spectra, we calculated the pDgN CT values for HVL ranging between 1.25 mm Al and 1.50 mm Al, obtained by tuning the Al filter thickness. The spectra were computed as suggested in Ref. [51] . A layer of 2 mm of PMMA was added during the spectra calculation in order to take into account the protective plastic cup, which is present in the Koning Corp. BCT units [28] .
The pDgN coefficients computed within this work have been compared to those in Ref. [28] for breast glandular fraction of 14.3%, 25%, Fig. 1 . Irradiation geometry adopted in this work.
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Physica Medica 51 (2018) [99] [100] [101] [102] [103] [104] [105] [106] [107] 50% and 100%. The spectrum adopted in such a work was replicated and the added Al filtration was tuned in order to have a 1st HVL of 1.39 mm Al.
Patient specific digital phantoms
The homogeneous cylindrical breast model was compared to patient specific digital breast phantoms in terms of MGD and glandular dose distribution. The patient specific models reflect the real breast anatomy and shape and were produced from two cohorts of 3D images of uncompressed breasts acquired at Emory University (Georgia -USA) with the Koning Corp. BCT apparatus, and at UC Davis (California -USA) with their in-house developed prototype [43] .
Cohort from Emory University
Twenty 3D images of uncompressed breasts from twenty patients were acquired via the Koning Corp. BCT scanner at Emory University with a W spectrum (1st HVL of 1.39 mm Al) over a 360 deg CT scan angle. Using a segmentation algorithm, the image voxels (0.273 × 0.273 × 0.273 mm 3 ) were classified into four categories: air, skin, adipose and glandular tissue. The classification process is fully described in Ref. [52] . Fig. 2 shows a coronal, a sagittal and an axial view of one of the 20 classified breast images. Table 1 summarizes the characteristics of the cohort of the patient specific breast phantoms. For the comparison, the pDgN CT coefficients obtained for the homogeneous model were linearly interpolated or extrapolated on the basis of the breast characteristics (equivalent diameter at the chest-wall, breast length and glandular fraction by mass).
Cohort from UC Davis
An additional patient specific breast phantom was produced from a cohort of 200 breast images acquired via the prototype developed at UC Davis (California -USA, [43] ). This prototype presents specifications (geometry distances, spectra, etc.) different from the Koning Corp. apparatus used for producing the images cohort of the previous paragraph. The single image here selected was used to show a tissue classification algorithm and a preliminary MC study for exploring the influence of the heterogeneous tissue distribution on the glandular dose distribution. The coronal slices have a pixel pitch of 0.354 mm and the slice thickness is 0.206 mm. The breast glandular fraction by mass was 17.1% and the equivalent diameter at the chest wall, 12.4 cm. The image voxels were classified as air, skin, adipose tissue or gland via a routine written in Matlab 2016b which follows the workflow in Fig. 3 . The skin and the glandular tissue were classified separately, and then piled up. Voxels included within the skin boundary, which were not indicated as glandular tissue, were then classified as adipose tissue. Before the classification, a cupping artefact correction was applied by the group of UC Davis [43] . This patient specific breast phantom was used to calculate the dose distribution within the glandular tissue. For comparison, the glandular dose distribution was also scored for a homogeneous cylindrical phantom with the same characteristics of the patient specific one (diameter at the chest-wall, height and glandular fraction by mass) (Fig. 4) . For this purpose, the interaction position was scored along with the locally absorbed glandular dose allocated in a scoring matrix with a coronal pixel pitch of 0.354 mm and a slice thickness of 0.206 mm. In the case of the homogeneous phantom, in order to reduce statistical fluctuations the scoring matrix slices were binned in the coronal planes (2 × 2 binning). Moreover, the homogeneous phantom was a cylindrical non-voxelized phantom, and, in order to have a finer MGD estimate (the mean value of the distribution), this is estimated directly in the code, rather than from the computed histogram. Indeed, due to the boundary condition, a voxel can contain both the adipose/fat mixture and the skin, and the mean value from the dose histogram could contain some bias.
Monte Carlo validation
The Monte Carlo code used in this work was previously validated versus literature data [45] and measurements [46] . In particular, it was validated following the tests suggested in the AAPM TG 195 Report [53] . The results obtained with our code for case 3 described in the report, concerning the MGD to the breast during a mammographic examination, differ by less than 0.5% from those provided by the report [44] . In this work, in the case of homogeneous breast model, which presents a cylindrical symmetry, the source was not rotated, so no further validation tests were necessary.
On the other hand, in the case of patient specific breast phantoms, the glandular tissue is distributed within the breast and the organ silhouette is arbitrary. This implies that the X-ray source had to rotate during the breast irradiation for simulating the real scanning geometry. Moreover, the glandular dose is scored voxel-by-voxel, and the G-factor, as described in Eqs. (2) and (3) is not employed in the calculation. Such differences require further MC code validation. In order to test the code, ten voxelized cylinders with a diameter of 14 cm and a height of 1.5 times the radius were generated. The skin thickness was set to 2 mm and the glandular fraction by mass was 20%. The voxels were made either of 100% glandular tissue or of 100% adipose tissue. The glandular voxels were placed randomly within the breast adipose tissue. The number of the glandular voxels has been evaluated as suggested in Ref. [44] . In this case, the source rotated over a scan angle of 360 deg. Finally, the calculated MGD has been compared to that of a 20% glandular homogeneous breast, for each single energy in the range 8-80 keV.
Results
Monte Carlo validation
Fig . 5 shows the ratio between the monoenergetic DgN CT (E) vs. E evaluated with the homogeneous breast phantom and those evaluated with a heterogeneous breast model with 100% glandular voxels randomly placed within the adipose tissue. As shown in previous papers [40, 44, 54] , a slight discrepancy, lower than ∼2%, in MGD values can be ascribed to the G-factor, which is not employed for the heterogeneous breast. Fig. 5 shows that no further bias is introduced by the source rotation. Fig. 6 shows the DgN CT (E) coefficient for a 25% homogeneous glandular breast with a diameter of 10 cm, for primary photon energy between 4.25 and 82.25 keV with a 0.5 keV step. The data calculated with MC simulation are indicated with symbols, and the continuous lines are 8th-order polynomial fitting curves (with constant term forced to 0). For data in Fig. 6 , the R 2 fitting parameter is higher than 0.9999, indicating that these fitting functions can be adopted for approximating DgN CT (E) coefficients in the investigated energy range. Appendix A contains fitting coefficients for all the DgN CT (E) computed in this work. Fig. 6 shows that, in the explored energy range, DgN CT (E) increases as photon energy increases; moreover, at all energies, the smaller the breast height, the lower is the corresponding DgN CT (E). 6 . Values of DgN CT (E) for 25% glandular breast, vs. photon energy. The breast is modelled as a cylinder with a diameter of 10 cm and a height equal to 1, 1.5 or 2 times its radius.
Monoenergetic curve fit for homogeneous breast model
Influence of the skin thickness on the DgN CT (E)
In mammography, the modelled breast skin can drastically influence the estimated MGD [44] . However, in BCT, harder spectra are adopted and the skin influence reduces. Fig. 7 shows the ratio between the DgN CT (E) calculated for a model breast with a skin thickness of 4 mm, 3 mm or 2 mm and those for 1.45 mm (glandular fraction by mass = 20%, breast diameter 14 cm, breast height = 1.5 times the radius). Fig. 7 shows that modelling the skin layer as 4 mm thick instead of 1.45 mm leads to a lower DgN CT (E) by 17.0% for a monoenergetic beam at 20 keV. This difference decreases to 4.7% at 30 keV photon energy and to 1.5% at 40 keV. At the same energies, the DgN CT (E) coefficients evaluated for a breast with a skin thickness of 2 mm are lower by 4.0%, 1.0% and 0.3% than the model with a 1.45 mm skin thickness, respectively. Fig. 8 shows the pDgN CT evaluated at 49 kVp for a 25% glandular breast, with a breast diameter ranging between 8 cm and 18 cm and with the breast height equal to 1.5 times the radius, as a function of the beam HVL. It shows the pDgN CT dependence on the beam HVL. For instance, for a 25% glandular breast with a diameter of 12 cm at the chest wall, the pDgN coefficient increases by 12% when increasing the HVL from 1.25 mm Al to 1.5 mm Al. Appendix B in the Supplementary material contains tables of pDgN CT coefficients for all simulated breasts and X-ray spectra. Fig. 9 shows a scatter plot of the pDgN CT from Sechopoulos et al. [28] vs. pDgN CT coefficients provided in this work. The slope of the linear fit to the data point (1.13) shows that the former data are, on average, 13% higher than the coefficients in this work. Such a difference can be attributed to the different breast models in the two reports. Indeed, Sechopoulos et al. [28] modelled the breast with a semi-elliptical shape with respect to the cylindrical shape adopted here. This difference in the breast model shape was shown to cause quantitative differences in DgN CT similar to those in Fig. 9 [27] . In addition, it is worth noting that the spectral model adopted in ref [28] is different from the one adopted here.
Polyenergetic DgN CT
Homogeneous model vs patient specific breast phantoms
We compared the pDgN CT coefficients evaluated for the homogeneous cylindrical breast model with those evaluated for patient specific breast phantoms (Fig. 10) . For this case, a polyenergetic beam at 49 kVp and with a HVL of 1.40 mm Al was simulated. The pDgN CT coefficients evaluated by means of the homogeneous model were then evaluated for each breast, interpolating the data on the basis of the breast characteristics (diameter at the chest wall, glandular fraction by mass and breast length). The whiskers plot in Fig. 10 shows the ratio between the pDgN CT for the homogeneous case and those for the patient specific case. The ratio is 1.08, on average, indicating that the homogeneous model leads to an MGD average overestimation of 8%. About 65% of all the breasts presents MGD estimates which differ less than 10% between the two models. The homogeneous model results in a dose overestimation of 27% for one breast; the maximum underestimation observed is 15%. Fig. 11 shows sample slices drawn from the 3D glandular dose distribution calculated for the patient specific breast phantom indicated in Fig. 4 . The glandular dose is expressed in mGy per incident photon. Comparison between pDgN computed within this work and those in Ref. [28] . The data point are fitted with a linear trend whose slope is 1.13. Physica Medica 51 (2018) [99] [100] [101] [102] [103] [104] [105] [106] [107] For comparison, the glandular dose distribution was scored also within a homogeneous cylindrical breast phantom having the same geometry as the patient model (diameter at the chest wall, glandular fraction by mass and breast length). For the homogeneous phantom, the lowest levels of glandular dose in the inner regions of the breast are evident, with a cup-shaped distribution in the coronal view. For the heterogeneous phantom, the glandular tissue and hence the absorbed dose are localized in defined regions: for this specific patient, the gland is confined to peripheral regions of the breast toward the skin, where the dose is higher. Fig. 12a shows dose histograms corresponding to the two digital phantoms indicated in Fig. 11 . The case shown is taken as representative of the type and extent of differences in the volume distribution of glandular dose when the specific breast anatomy is taken into account, with respect to a homogeneous simple model. In this specific case, the MGD calculated for the homogeneous model was only 2% higher than for the patient specific breast phantom. The dose spread around the mean value (as expressed by the distribution standard deviation) was 52% of the mean value for the patient specific case, and 41% of the MGD for the homogeneous model. However, a χ 2 -test showed that the two histograms are not significantly different, with a confidence level of 95%. Fig. 12b reports the cumulative dose distribution for the two cases; the x-axis is normalized to the MGD of each model. In the homogeneous case, about 15% of the glandular tissue receives less than 0.5 times the MGD. On the other hand, in the heterogeneous patient specific phantom, where the adipose tissue close to the skin partially shields the gland, about 20% of the glandular tissue receives a dose less than 0.5 times the MGD. However, part of the glandular tissue in the patient specific phantom was close to the skin tissue. An example is the gland close to the nipple in Fig. 11 . In this region, which is shielded from the radiation exclusively by the skin layer, high glandular dose level can be observed. In fact, in the homogeneous region, the sole 1% of the glandular tissue receives a dose higher than 2 times the mean glandular dose. In the patient specific case, up to 4% of the glandular mass receives a dose level higher than 2 times the calculated MGD (Fig. 12b) . This may be due to the high dose level to the gland close to the nipple, as in the case of that specific patient.
Discussion
BCT as a new 3D breast imaging modality has entered the clinical practice, though not the clinical routine in breast cancer diagnosis. However, there is no universal protocol for glandular dose estimation with pDgN CT coefficients. For the UC Davis BCT scanners, a dataset for pDgN CT is available [26] , while for the Koning Corp. BCT scanner the weighted computed tomography dose index value has been reported (e.g. CTDIw = 8 mGy ± 20% with one 360°scan at 49 kVp, 100 mA, and 8 ms pulse duration) [9] . Reports indicate that in BCT exams the MGD can be comparable to that of diagnostic mammography [9, 10, 55] , and several times larger than that used in two-view screening mammography [28, 56] . Sechopoulos et al. [28] calculated the pDgN CT coefficients for the Koning Corp. scanner located at the Emory University (whose scans are adopted in this work, with beam quality 49 kVp and HVL = 1.39 mm Al). With respect to data in Ref. [28] , the pDgN CT calculated in this work are lower by 13%. This was attributed to the different geometry of the simulated breasts (cylindrical in our case vs. semi-ellipsoidal in Ref. [20] ).
When considering a cohort of 20 BCT scans with the Koning Corp scanner, the difference in pDgN CT (and hence in MGD values) between the homogeneous and patient specific model is 8% (with the homogeneous model providing higher values of pDgN CT than patient specific models).
Assumptions on the breast shape and composition play a role in glandular dose estimation, in mammography as well as in DBT and in BCT. Both the breast silhouette [43] and the glandular distribution [29, 41] have some impact on the DgN CT coefficients calculation and should be considered in the model. The MGD in a BCT scan should be estimated before the exam also for providing a dose comparison with other breast exams. However, an ad hoc calculation of the patient specific MGD after the exam − using a breast model based on the 3D BCT breast images − is not clinically practical, due to the large computation time. Indeed, both the breast tissue classification (using suitable image segmentation algorithms) and the MC simulations for patient specific estimates are time-consuming processes (in the order of several hours in our experience). On the other hand, this work showed that the adoption of a breast model derived from BCT scans produced pDgN CT values which differ slightly (8% on the average) from those obtained with homogenous mixture cylindrical model. The differences ranged between an MGD overestimation of 27% and an MGD underestimation of 15% for the homogenous model, among all the considered patient specific breast phantoms. About 65% of the considered cases outlined differences between the MGD estimated via homogeneous cylindrical breast model and that estimated via patient specific breast phantom of less than 10% (absolute value). Since several breast characteristics contribute to the MGD determinations we think that the main contribution in the variation comes from the glandular distribution within the breast volume. For this reason, we started exploring the possibility of using models from the software platform BreastSimulator, which can be used to produce 3D breast models highly conformal to the anatomy of real breasts [54, 57] .
In the comparison between the glandular dose distribution in a homogeneous model and that in a patient specific phantom the low glandular dose level for the glandular tissue located at the inner part is compensated by the high values of the dose for the tissue located close to the nipple, so resulting in a negligible MGD difference. However, different breasts with different glandular distribution and different spectra may produce different results. A comparative study with a larger cohort of digital patient specific breast phantoms is planned for future work.
Conclusions
We have calculated and released a complete dataset of monoenergetic and polyenergetic DgN CT coefficients for MGD estimates in BCT. The former was fit with 8th-order polynomial curves and the fitting coefficients were tabulated. The original dataset of the DgN CT (E) coefficients, not affected by the interpolation process, is available by email to the corresponding author. The polyenergetic coefficients were computed for 49 kV produced with a W-anode, as used by the FDA approved and CE marked Koning Corp. apparatus. For fixed breast characteristics, the polyenergetic DgN CT have been calculated for various beam HVL, in order to be used for different apparatuses. The data calculated with a simple homogeneous cylindrical breast models were compared to those calculated by means of patient specific breast phantoms, which reflect both breast silhouette and glandular tissue distribution. The homogenous model overestimated the MGD by 8%, on average.
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